|Articles|October 1, 2011
- Pharmaceutical Executive-10-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - October 2011
Thirty Years of Pharm Exec
Advertisement
Articles in this issue
almost 15 years ago
Y. K Hamied : Changing the Dialoguealmost 15 years ago
Fred Frank: Fortune and the Financieralmost 15 years ago
Marck McLellan: An 'A' for Advancing Expectationsalmost 15 years ago
Inside the Mind of the CEO: Steve Collisalmost 15 years ago
Atsushi Nagahisa: Creating Customer Valuealmost 15 years ago
Physicians: Still the Vital Connection in Medicinealmost 15 years ago
Henry Waxman: "Representing" Healthcare to the Fullestalmost 15 years ago
IP: Securing a Global Consensus—Can Industry Do It Again?almost 15 years ago
In Establishing the Evidence Base, He Made Science Countalmost 15 years ago
Jane Henney: Lessons from the FDA Front LineAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
3
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
4
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
5